Virtus ETF Advisers’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-6,808
| Closed | -$67K | – | 475 |
|
|
2023
Q1 | $67K | Sell |
6,808
-2,618
| -28% | -$25.8K | 0.04% | 406 |
|
|
2022
Q4 | $139K | Buy |
9,426
+1,789
| +23% | +$26.3K | 0.07% | 369 |
|
|
2022
Q3 | $93K | Buy |
7,637
+51
| +0.7% | +$621 | 0.04% | 423 |
|
|
2022
Q2 | $106K | Sell |
7,586
-305
| -4% | -$4.26K | 0.04% | 417 |
|
|
2022
Q1 | $112K | Sell |
7,891
-464
| -6% | -$6.59K | 0.05% | 285 |
|
|
2021
Q4 | $176K | Buy |
8,355
+1,873
| +29% | +$39.5K | 0.07% | 261 |
|
|
2021
Q3 | $170K | Sell |
6,482
-346
| -5% | -$9.07K | 0.07% | 311 |
|
|
2021
Q2 | $213K | Sell |
6,828
-784
| -10% | -$24.5K | 0.09% | 301 |
|
|
2021
Q1 | $234K | Buy |
7,612
+143
| +2% | +$4.4K | 0.1% | 304 |
|
|
2020
Q4 | $256K | Buy |
+7,469
| New | +$256K | 0.11% | 304 |
|